Shigeo Fuji. "Late Nonrelapse Mortality: A Hidden Risk in Triplet Therapy for
                    <i>IDH</i>
                    -Mutated AML?." Journal of Clinical Oncology, 2026. doi:10.1200/jco-25-01666